Substituted pyrrolidine compound and use thereof
US11034700B2 · kind B2 · utility
1Cited by
3References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 7, 2018 |
| Grant date | Jun 15, 2021 |
| Priority date | — |
| Expiry date | Apr 8, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a substituted pyrrolidine compound having an orexin type 2 receptor agonist activity.A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof, has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.